Trial intelligence / Profile preview

Prognostic Factors After Steroid Hydrodilatation for Frozen Shoulder

NCT03622853Unknown

Sponsor
Taipei Veterans General Hospital
Start
Jan 2018
Primary completion
Mar 2019
Modality
Orthosteric Ligands
Countries
1
01

Overview

Open-label, single-arm trial of triamcinolone acetonide in adhesive capsulitis (AC), sponsored by Taipei Veterans General Hospital. Primary endpoint: Change of Constant Shoulder Score at 8 weeks. Status: unknown.

02

Drugs

triamcinolone acetonide
03

Conditions

adhesive capsulitis (AC)

Beyond the preview

Go deeper on NCT03622853.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03622853.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call